Advanced Biomed Inc (ADVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,174 | -266 | 0 | -1,973 | -917 |
| Depreciation Amortization | 46 | 102 | 0 | 246 | 163 |
| Other Working Capital | 60 | 134 | 0 | 97 | 189 |
| Other Operating Activity | 196 | 0 | 0 | -20 | -20 |
| Operating Cash Flow | $-872 | $-30 | $0 | $-1,651 | $-585 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -20 | 0 | -21 | -48 |
| Investing Cash Flow | $-9 | $-20 | $0 | $-21 | $-48 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 507 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | 205 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 204 | N/A | 228 | 551 |
| Common Stock Repurchased | -2 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 296 | -17 | 0 | 1,315 | 430 |
| Financing Cash Flow | $801 | $393 | $0 | $1,543 | $981 |
| Exchange Rate Effect | 129 | -304 | 0 | 170 | -194 |
| Beginning Cash Position | 2,608 | 2,608 | 0 | 2,622 | 2,622 |
| End Cash Position | 2,657 | 2,647 | 0 | 2,664 | 2,777 |
| Net Cash Flow | $49 | $39 | $0 | $41 | $154 |
| Free Cash Flow | |||||
| Operating Cash Flow | -872 | -30 | 0 | -1,651 | -585 |
| Capital Expenditure | -9 | -20 | N/A | -21 | -48 |
| Free Cash Flow | -881 | -50 | 0 | -1,671 | -633 |